Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Xaira Therapeutics
Biotech
Buzzy AI biotech Xaira unveils antibody platform ambitions
CEO Marc Tessier-Lavigne, Ph.D., told Fierce of Xaira's “major focus to develop a model that can design antibodies that are drug-ready from the start”
Darren Incorvaia
Oct 2, 2026 11:00am
Idorsia locks in new CEO after shakeup—Chutes & Ladders
Jul 10, 2026 8:30am
Tang takes over Aurinia after FDA brouhaha—Chutes & Ladders
Mar 27, 2026 11:05am
What Xaira is building after its $1B fundraise
Mar 20, 2026 10:34am
After $1B fundraise, Xaira breaks silence on AI work
Mar 17, 2026 2:52pm
Pfizer’s reputation wrangler plans departure—Chutes & Ladders
Jul 11, 2025 8:30am